The following article, “Gene Therapy: Where Are We Now and What’s on the Horizon,” which appears in this month’s Hemaware magazine, highlights research presented at the National Hemophilia Foundation’s 16th Workshop on Novel Technologies and Gene Transfer for Hemophilia, held back in November 2021 in Washington, DC. It includes a concise recap of exciting advances occurring in the field of gene and other novel therapies. The update also provides background on the fundamental science underpinning gene therapy and hemophilia genetics, for those who may be new to the subject. To access the article, please click here or email

To sign up to regularly receive Hemaware magazine, click here.